Aerie Pharmaceuticals Inc

Candriam S.C.A.

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/10/2022

Shares

142,745

Value ($000)

2,160

Weight

0.0%

2019 Q3 - 2022 Q3 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/10/2022	2,160	0.0%	142,745	9/30/2022
2021 Q4	2/10/2022	1,060	0.0%	151,000	12/31/2021
2021 Q1	4/29/2021	7,481	0.1%	576,495	3/31/2021
2020 Q4	1/22/2021	7,789	0.1%	576,495	12/31/2020
2020 Q3	10/19/2020	6,965	0.1%	591,800	9/30/2020
2020 Q2	7/23/2020	8,735	0.1%	591,800	6/30/2020
2020 Q1	5/26/2020	15,826	0.2%	669,800	3/31/2020
2019 Q4	2/5/2020	16,189	0.2%	669,800	12/31/2019
2019 Q3	2/5/2020	13,450	0.2%	699,800	9/30/2019